Oncolytics, (ONCY) Climbs 2.69% on May 13

Equities Staff  |

Shares of Oncolytics Biotech, Inc. (NASDAQ: ONCY) moved 2.69% Friday.

As of 11:56:15 est, Oncolytics, is currently sitting at $1.15 and has climbed $0.03 per share.

Oncolytics, has moved 27.60% over the last 30 days and has a YTD change of 19.78% based on the previous close.

The company expects its next earnings on 2022-08-05.

For technical charts, analysis, and more on Oncolytics, visit the company profile.

About Oncolytics Biotech, Inc.

Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype -- turning 'cold' tumors 'hot' -- through innate and adaptive immune responses to treat a variety of cancers.

To get more information on Oncolytics Biotech, Inc. and to follow the company's latest updates, you can visit the company's profile page here: Oncolytics Biotech, Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Cisco Down 12% in Premarket Trading Thursday After Top Line Miss and Lower Forecast
Under Armour CEO Patrik Frisk To Step Down in Surprise Announcement
Target Hits 52-Week Low After Missing Badly on First Quarter Earnings
DLocal Posts Record Q1, Fifth Consecutive 100%+ Revenue Growth Quarter
Another Crypto Winter Wipes Out Billions in Market Value
Inflation + Recession = Recipe for Volatility

Market Movers

Sponsored Financial Content